Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Characteristics and correlates of cognitive functioning following bone marrow transplantation

Summary:

Patients who undergo bone marrow transplantation (BMT) often report cognitive problems following treatment. This study used cognitive tests and a self-report measure of subjective cognitive complaints to determine (1) the rate of objective cognitive impairment in a sample of 65 BMT patients, and (2) the correspondence of patients' cognitive complaints to their actual cognitive performance. At 6 months following BMT, patients were assessed in seven cognitive domains – attention, verbal learning, verbal memory, visual memory, simple executive function, complex executive function, and psychomotor speed. Cognitive complaints were likewise assessed. In all, 51% had at least mild impairment (−1 standard deviation (s.d.) below published norms) in one or more cognitive domains, with 28% demonstrating moderate-to-severe impairment (−2 s.d.). Older patients and patients with lower IQ were more likely to score in the impaired range on objective cognitive tests, with males and the less educated showing trends toward scores in the impaired range. Younger patients made significantly more cognitive complaints. Total cognitive complaints were unrelated to average cognitive performance, and complaints in specific cognitive domains were largely unrelated to objective performance on corresponding domains. Findings suggest that patients who complain about their cognitive performance following BMT differ from those who experience actual deficits.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Goldman JM, Horowitz MM . The international bone marrow transplant registry. Int J Hematol 2002; 76: 393–397.

    Article  Google Scholar 

  2. National Bone Marrow Donor Program. Number of Allogeneic Transplants Performed, January 2005. http://www.marrow.org/PHYSICIAN/numberofallogeneictransplants.html.

  3. Saleh US, Brocktopp DY . Quality of life one year following bone marrow transplantation: psychometric evaluation of the quality of life in bone marrow transplant survivors tool. Oncol Nurs Forum 2001; 28: 1457–1464.

    CAS  PubMed  Google Scholar 

  4. Meyers CA, Weitzner M, Byrne K et al. Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. J Clin Oncol 1994; 12: 820–826.

    Article  CAS  Google Scholar 

  5. van Dam F, Schagen SB, Muller MJ et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose vs standard-dose chemotherapy. J Natl Cancer Inst 1998; 90: 210–218.

    Article  CAS  Google Scholar 

  6. Mattis S . Dementia Rating Scale. Professional Manual. Psychological Assessments Resources, Inc: Odessa, FL, 1988.

    Google Scholar 

  7. Schagen SB, Hamburger HL, Muller MJ et al. Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. J Neuro Oncol 2001; 51: 159–165.

    Article  CAS  Google Scholar 

  8. Harder H, Cornelissen JJ, Van Gool AR et al. Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer 2002; 95: 183–192.

    Article  Google Scholar 

  9. Syrjala KL, Dikmen S, Langer SL et al. Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. Blood 2004; 104: 3386–3392.

    Article  CAS  Google Scholar 

  10. Radloff LS . The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385–401.

    Article  Google Scholar 

  11. Beeber LS, Shea J, McCorkle R . The Center for Epidemiologic Studies Depression Scale as a measure of depressive symptoms in newly diagnosed patients. J Psychosoc Oncol 1998; 16: 1–20.

    Article  Google Scholar 

  12. Hann DH, Winter K, Jacobsen P . Measurement of depressive symptoms in cancer patients: Evaluation of the Center for Epidemiological Studies' Depression Scale (CES-D). J Psychosom Res 1999; 5: 437–443.

    Article  Google Scholar 

  13. Ware JE, Snow KK, Kosinski M, Gandek B . SF-36 Health Survey Manual and Interpretation Guide. The Health Institute, The New England Medical Center: Boston, MA, 1993.

    Google Scholar 

  14. Ware JE, Kosinski M, Keller SD . SF-36 Physical and Mental Health Summary Scales: A User's Manual. The Health Institute, The New England Medical Center: Boston, MA, 1994.

    Google Scholar 

  15. Hann DM, Jacobsen PB, Azzarello LM et al. Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res 1998; 7: 301–310.

    Article  CAS  Google Scholar 

  16. Hann DM, Denniston MM, Baker F . Measurement of fatigue in cancer patients: further validation of the Fatigue Symptom Inventory. Qual Life Res 2000; 9: 847–854.

    Article  CAS  Google Scholar 

  17. Seidenberg M, Haltiner A, Taylor MA et al. Development and validation of a multiple ability self-report questionnaire. J Clin Exp Neuropsychol 1994; 16: 93–104.

    Article  CAS  Google Scholar 

  18. Nelson HE . The National Adult Reading Test (NART) Test Manual. NFER-Nelson: Windsor, Berks, UK, 1982.

    Google Scholar 

  19. Crawford JR, Parker DM, Stewart LE et al. Prediction of WAIS IQ with the National Adult Reading Test: cross validation and extension. Br J Clin Psych 1989; 28: 267–273.

    Article  Google Scholar 

  20. Benton AL, Hamsher KdeS . Multilingual Aphasia Examination. AJA Associates: Iowa City, IA, 1989.

    Google Scholar 

  21. Spreen O, Strauss E . A Compendium of Neuropsychological Tests: Second Edition. The Oxford University Press: New York, 1998.

    Google Scholar 

  22. Reitan RM, Wolfson D . The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Neuropsychology Press: Tucson, AZ, 1993.

    Google Scholar 

  23. Reitan RM . The validity of the Trail Making Test as an indicator of organic brain damage. Percept Motor Skills 1958; 8: 271–276.

    Article  Google Scholar 

  24. Brandt J . Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol 1991; 5: 125–142.

    Article  Google Scholar 

  25. Wechsler D . Wechsler Adult Intelligence Scale: Revised Administration and Scoring Manual. The Psychological Corporation: San Antonio, TX, 1981.

    Google Scholar 

  26. Lezak M . Neuropsychological Assessment, 3rd edn. Oxford University Press: New York, 1995.

    Google Scholar 

  27. Matthews CG, Klove H . Instruction Manual for the Adult Neuropsychology Test Battery. University of Wisconsin Medical School: Madison, WI, 1964.

    Google Scholar 

  28. Wechsler D . Wechsler Memory Scale-III Manual. The Psychological Corporation: San Antonio, TX, 1997.

    Google Scholar 

  29. Trenarry MR, Crosson B, DeBoe J, Leber WR . The Stroop Neuropsychological Screening Test. Psychological Assessment Resources: Lutz, FL, 1989.

    Google Scholar 

  30. Grant DA, Berg EA . A behavioral analysis of degree of impairment and ease of shifting to new responses in a Weigl-type card sorting problem. J Exp Psychol 1948; 39: 404–411.

    Article  Google Scholar 

  31. Heaton RK . Comprehensive Norms for an Expanded Halstead–Reitan Battery: A Supplement for the Wechsler Adult Intelligence Scale – Revised (WAIS-R). Psychological Assessments Resources: Odessa, FL, 1992.

    Google Scholar 

  32. Heaton RK, Grant I, Matthews CG . Comprehensive Norms for an Expanded Halstead–Reitan Battery: Demographic Correction, Research Findings, and Clinical Applications. Psychological Assessments Resources Inc.: Odessa, FL, 1991.

    Google Scholar 

  33. Cull A, Hay C, Love SB et al. What do patients mean when they complain of concentration and memory problems? Br J Cancer 1996; 74: 1674–1679.

    Article  CAS  Google Scholar 

  34. Bartynski WS, Grabb BC, Zeigler Z et al. Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Computer Assist Tomogr 1997; 21: 872–880.

    Article  CAS  Google Scholar 

  35. Shah AK . Cyclosporine: a neurotoxicity among bone marrow transplant recipients. Clin Neuropharmacol 1999; 22: 67–73.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the American Cancer Society – Institutional Research Grant entitled ‘Prevalence and Impact of Cognitive Sequelae of BMT’, Margaret Booth-Jones, principal investigator. We are grateful to Christine Marsella and Lori Deitz for editorial support. We thank Karen K Fields, MD, former Program Leader of the Moffitt Cancer Center Blood and Marrow Transplant Program, for her support of psychosocial studies with her patients.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Booth-Jones.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Booth-Jones, M., Jacobsen, P., Ransom, S. et al. Characteristics and correlates of cognitive functioning following bone marrow transplantation. Bone Marrow Transplant 36, 695–702 (2005). https://doi.org/10.1038/sj.bmt.1705108

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705108

Keywords

This article is cited by

Search

Quick links